
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4813312
[patent_doc_number] => 20080193943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Companion diagnostic assays for cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 12/004227
[patent_app_country] => US
[patent_app_date] => 2007-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13452
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193943.pdf
[firstpage_image] =>[orig_patent_app_number] => 12004227
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/004227 | Companion diagnostic assays for cancer therapy | Dec 19, 2007 | Abandoned |
Array
(
[id] => 4676144
[patent_doc_number] => 20080213774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Mutations in Kit Confer Imatinib Resistance in Gastrointestinal Stromal Tumors'
[patent_app_type] => utility
[patent_app_number] => 11/957639
[patent_app_country] => US
[patent_app_date] => 2007-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28866
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213774.pdf
[firstpage_image] =>[orig_patent_app_number] => 11957639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/957639 | Mutations in Kit Confer Imatinib Resistance in Gastrointestinal Stromal Tumors | Dec 16, 2007 | Abandoned |
Array
(
[id] => 6580775
[patent_doc_number] => 20100129806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'REGULATION OF CELL SURVIVAL BY HSP90 AND IP6K2'
[patent_app_type] => utility
[patent_app_number] => 12/514254
[patent_app_country] => US
[patent_app_date] => 2007-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 8731
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129806.pdf
[firstpage_image] =>[orig_patent_app_number] => 12514254
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/514254 | Regulation of cell survival by HSP90 and IP6K2 | Dec 10, 2007 | Issued |
Array
(
[id] => 8446060
[patent_doc_number] => 08288110
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-16
[patent_title] => 'Biomarkers for detecting cancer'
[patent_app_type] => utility
[patent_app_number] => 11/950416
[patent_app_country] => US
[patent_app_date] => 2007-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 30380
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11950416
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/950416 | Biomarkers for detecting cancer | Dec 3, 2007 | Issued |
Array
(
[id] => 4852488
[patent_doc_number] => 20080318231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => '14-3-3 ZETA OVER-EXPRESSION AS A POOR PROGNOSIS FACTOR, AND A THERAPEUTIC TARGET IN MULTIPLE CANCER TYPE'
[patent_app_type] => utility
[patent_app_number] => 11/950264
[patent_app_country] => US
[patent_app_date] => 2007-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25973
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318231.pdf
[firstpage_image] =>[orig_patent_app_number] => 11950264
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/950264 | 14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer type | Dec 3, 2007 | Issued |
Array
(
[id] => 6430983
[patent_doc_number] => 20100143359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'EXPRESSION OF FOXP3 BY CANCER CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/312472
[patent_app_country] => US
[patent_app_date] => 2007-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 32372
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20100143359.pdf
[firstpage_image] =>[orig_patent_app_number] => 12312472
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/312472 | Expression of FoxP3 by cancer cells | Nov 26, 2007 | Issued |
Array
(
[id] => 6581199
[patent_doc_number] => 20100129829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'USE OF PLASMA HSP90 RELATED TO MALIGNANCY'
[patent_app_type] => utility
[patent_app_number] => 12/515770
[patent_app_country] => US
[patent_app_date] => 2007-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21553
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129829.pdf
[firstpage_image] =>[orig_patent_app_number] => 12515770
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/515770 | Use of plasma HSP90 related to malignancy | Nov 25, 2007 | Issued |
Array
(
[id] => 5284441
[patent_doc_number] => 20090098116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'IMMUNOGENIC COMPOSITIONS FOR INDUCTION OF ANTI-TUMOR IMMUNITY'
[patent_app_type] => utility
[patent_app_number] => 11/943255
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9017
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098116.pdf
[firstpage_image] =>[orig_patent_app_number] => 11943255
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/943255 | IMMUNOGENIC COMPOSITIONS FOR INDUCTION OF ANTI-TUMOR IMMUNITY | Nov 19, 2007 | Abandoned |
Array
(
[id] => 4845849
[patent_doc_number] => 20080182257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'DETECTION OF CHROMOSOMAL REGION COPY NUMBER CHANGES TO DIAGNOSE MELANOMA'
[patent_app_type] => utility
[patent_app_number] => 11/941002
[patent_app_country] => US
[patent_app_date] => 2007-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15002
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182257.pdf
[firstpage_image] =>[orig_patent_app_number] => 11941002
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/941002 | Detection of chromosomal region copy number changes to diagnose melanoma | Nov 14, 2007 | Issued |
Array
(
[id] => 4765025
[patent_doc_number] => 20080176236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'MATERIALS AND METHODS FOR PROGNOSING LUNG CANCER SURVIVAL'
[patent_app_type] => utility
[patent_app_number] => 11/940707
[patent_app_country] => US
[patent_app_date] => 2007-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10377
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176236.pdf
[firstpage_image] =>[orig_patent_app_number] => 11940707
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/940707 | Materials and methods for prognosing lung cancer survival | Nov 14, 2007 | Issued |
Array
(
[id] => 4867451
[patent_doc_number] => 20080146510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'BIOLOGICALLY ACTIVE PEPTIDE VAPEEHPTLLTEAPLNPK DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/930093
[patent_app_country] => US
[patent_app_date] => 2007-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18828
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20080146510.pdf
[firstpage_image] =>[orig_patent_app_number] => 11930093
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/930093 | BIOLOGICALLY ACTIVE PEPTIDE VAPEEHPTLLTEAPLNPK DERIVATIVES | Nov 4, 2007 | Abandoned |
Array
(
[id] => 8571465
[patent_doc_number] => 08338109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Predicting cancer outcome'
[patent_app_type] => utility
[patent_app_number] => 12/513329
[patent_app_country] => US
[patent_app_date] => 2007-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13854
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12513329
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513329 | Predicting cancer outcome | Nov 1, 2007 | Issued |
Array
(
[id] => 4677156
[patent_doc_number] => 20080214787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'MN Gene and Protein'
[patent_app_type] => utility
[patent_app_number] => 11/933180
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 33414
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214787.pdf
[firstpage_image] =>[orig_patent_app_number] => 11933180
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/933180 | MN Gene and Protein | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4699125
[patent_doc_number] => 20080221309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'MN Gene and Protein'
[patent_app_type] => utility
[patent_app_number] => 11/932697
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 33407
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221309.pdf
[firstpage_image] =>[orig_patent_app_number] => 11932697
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/932697 | MN Gene and Protein | Oct 30, 2007 | Abandoned |
Array
(
[id] => 168843
[patent_doc_number] => 07667001
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-02-23
[patent_title] => 'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer'
[patent_app_type] => utility
[patent_app_number] => 11/978554
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 122
[patent_figures_cnt] => 127
[patent_no_of_words] => 335400
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/667/07667001.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978554
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978554 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer | Oct 29, 2007 | Issued |
Array
(
[id] => 113069
[patent_doc_number] => 07714100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease'
[patent_app_type] => utility
[patent_app_number] => 11/978203
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 53
[patent_no_of_words] => 139242
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/714/07714100.pdf
[firstpage_image] =>[orig_patent_app_number] => 11978203
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/978203 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease | Oct 28, 2007 | Issued |
Array
(
[id] => 4739985
[patent_doc_number] => 20080233638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/977647
[patent_app_country] => US
[patent_app_date] => 2007-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 35836
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20080233638.pdf
[firstpage_image] =>[orig_patent_app_number] => 11977647
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/977647 | PAAD domain-containing polypeptides, encoding nucleic acids, and methods of use | Oct 23, 2007 | Abandoned |
Array
(
[id] => 4915635
[patent_doc_number] => 20080096235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Biomarkers For Cancer Sensitivity And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/877234
[patent_app_country] => US
[patent_app_date] => 2007-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18416
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096235.pdf
[firstpage_image] =>[orig_patent_app_number] => 11877234
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/877234 | Biomarkers for cancer sensitivity and uses thereof | Oct 22, 2007 | Issued |
Array
(
[id] => 5324206
[patent_doc_number] => 20090062196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Compositions and methods of treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/975997
[patent_app_country] => US
[patent_app_date] => 2007-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 26415
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0062/20090062196.pdf
[firstpage_image] =>[orig_patent_app_number] => 11975997
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/975997 | Compositions and methods of treating cancer | Oct 21, 2007 | Abandoned |
Array
(
[id] => 4866790
[patent_doc_number] => 20080145849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Methods for diagnosing and treating neuroendocrine cancer'
[patent_app_type] => utility
[patent_app_number] => 11/875067
[patent_app_country] => US
[patent_app_date] => 2007-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12083
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145849.pdf
[firstpage_image] =>[orig_patent_app_number] => 11875067
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/875067 | Methods for diagnosing and treating neuroendocrine cancer | Oct 18, 2007 | Abandoned |